[A case of primary gastric malignant lymphoma perforated immediately after administration of chemotherapy].
A 77-year-old man was admitted to our hospital with complaints of abdominal pain and body weight loss. Esophagogastroduodenoscopy on admission revealed large ulcerative tumor in the entire region from upper to lower body of the stomach. We diagnosed gastric malignant lymphoma, diffuse large B-cell type and determined stage IV according to the Lugano International Conference classification. Due to gastric perforation occurred on day 4 of chemotherapy, total gastrectomy and partial resection of the transverse colon were performed. Complete remission was achieved by 2 cycles of postoperative chemotherapy together with rituximab.
Yoshino
Sohei
S
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University.
Nakamura
Shotaro
S
Matsumoto
Takayuki
T
Konomi
Hiroyuki
H
Hirahashi
Minako
M
Yao
Takashi
T
Iida
Mitsuo
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003520:Cyclophosphamide / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives; D006801:Humans; D016393:Lymphoma, B-Cell / Q000150:complications* / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications* / Q000188:drug therapy*; D008297:Male; D011239:Prednisolone / Q000009:adverse effects; D013272:Stomach Diseases / Q000139:chemically induced*; D013274:Stomach Neoplasms / Q000150:complications* / Q000188:drug therapy*; D014750:Vincristine / Q000009:adverse effects
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone